18 F-PSMA-1007 PET/CT in a Case of Von Hippel-Lindau Syndrome.

Authors :: Dong A
Zhao B
Wang L
Cheng C
Zuo C
Source :: Clinical nuclear medicine [Clin Nucl Med] 2023 Dec 01; Vol. 48 (12), pp. e600-e602. Date of Electronic Publication: 2023 Oct 11.
Publication Year :: 2023
Abstract: Abstract: We describe 18 F-PSMA-1007 PET/CT findings in case of von Hippel-Lindau syndrome with a cerebellar hemangioblastoma, 6 renal cell carcinomas in the bilateral kidneys, cystic lesions in the pancreas and left adrenal gland, and solid lesions in the bilateral epididymides. 18 F-PSMA-1007 PET/CT showed intense activity with SUV max of 111.3 of the cerebellar hemangioblastoma, variable activity with SUV max range of 6.4-37.6 of the renal cell carcinomas, and increased activity of the bilateral epididymal lesions (SUV max of 5.1 and 8.2 for the left and right epididymal lesions, respectively).<br />Competing Interests: Conflicts of interest and sources of funding: The authors declare no conflicts of interest. This work was supported by The First Affiliated Hospital of Naval Medical University “Guhai Plan in the 14th Five-Year Plan Period” (no. GH145XKQ-03) and Shanghai Hospital Development Center (no. SHDC12023103).<br /> (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)